Featured Article

Texas Children’s Hospital has delivered a novel gene therapy to treat Rett syndrome in two pediatric patients.

Precision Oncology Today

Magazine

The Digital Pathway to Widespread Precision Medicine

Digital health tools and technologies were thrust into the spotlight during the pandemic and were able to help many people get much needed medical...
Artificial Intelligence

Generative AI and Precision Medicine–The Future Is Not What It Used to Be

Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis, treatment, and drug discovery.
Person getting blood work

Pushing the Performance of Liquid Biopsies for Cancer with Nanotechnology

Nanotechnology opens the door to a range of unique methods for sensing cancer biomarkers in body fluids, thanks to the unusual properties and capabilities of nanoscale systems. Going small promises big gains in diagnosing and tracking a wide range of tumors.

Trending on Inside Precision Medicine

Woman with depression with head in hands

Alto Neuroscience Gets One Step Closer to Precision Depression Treatment

A third positive Phase II trial will help Alto Neuroscience progress precision psychiatry treatments for depression to the clinic.
Illustration of CAR T-cell immunotherapy.

Seattle Children’s CAR T Spinout BrainChild Bio Launches with a Focus on Pediatric CNS...

Research hospital Seattle Children’s announced today the spinout of its for-profit company BrainChild Bio, Inc., which will develop CAR T-cell therapies targeting pediatric central nervous system (CNS) cancers.
Scientist holding a DNA sample with the results on a computer sceeen in a laboratory

Texas Children’s Hospital Delivers First Gene Therapy for Rett Syndrome

Texas Children’s Hospital has delivered a novel gene therapy to treat Rett syndrome in two pediatric patients.

Daily News

Related Content

Inside Precision Medicine